5557 related articles for article (PubMed ID: 11553815)
1. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
Sørlie T; Perou CM; Tibshirani R; Aas T; Geisler S; Johnsen H; Hastie T; Eisen MB; van de Rijn M; Jeffrey SS; Thorsen T; Quist H; Matese JC; Brown PO; Botstein D; Lønning PE; Børresen-Dale AL
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10869-74. PubMed ID: 11553815
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis.
Korkola JE; DeVries S; Fridlyand J; Hwang ES; Estep AL; Chen YY; Chew KL; Dairkee SH; Jensen RM; Waldman FM
Cancer Res; 2003 Nov; 63(21):7167-75. PubMed ID: 14612510
[TBL] [Abstract][Full Text] [Related]
3. ESPL1 is a candidate oncogene of luminal B breast cancers.
Finetti P; Guille A; Adelaide J; Birnbaum D; Chaffanet M; Bertucci F
Breast Cancer Res Treat; 2014 Aug; 147(1):51-9. PubMed ID: 25086634
[TBL] [Abstract][Full Text] [Related]
4. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling.
Van Laere SJ; Van den Eynden GG; Van der Auwera I; Vandenberghe M; van Dam P; Van Marck EA; van Golen KL; Vermeulen PB; Dirix LY
Breast Cancer Res Treat; 2006 Feb; 95(3):243-55. PubMed ID: 16261404
[TBL] [Abstract][Full Text] [Related]
5. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast.
Zhao H; Langerød A; Ji Y; Nowels KW; Nesland JM; Tibshirani R; Bukholm IK; Kåresen R; Botstein D; Børresen-Dale AL; Jeffrey SS
Mol Biol Cell; 2004 Jun; 15(6):2523-36. PubMed ID: 15034139
[TBL] [Abstract][Full Text] [Related]
6. Increased RNA Expression of von Willebrand Factor Gene Is Associated With Infiltrating Lobular Breast Cancer and Normal PAM50 Subtype.
Lehrer S; Green S; Dembitzer FR; Rheinstein PH; Rosenzweig KE
Cancer Genomics Proteomics; 2019; 16(3):147-153. PubMed ID: 31018945
[TBL] [Abstract][Full Text] [Related]
7. RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype.
Habashy HO; Powe DG; Glaab E; Ball G; Spiteri I; Krasnogor N; Garibaldi JM; Rakha EA; Green AR; Caldas C; Ellis IO
Breast Cancer Res Treat; 2011 Jul; 128(2):315-26. PubMed ID: 20697807
[TBL] [Abstract][Full Text] [Related]
8. A gene expression signature identifies two prognostic subgroups of basal breast cancer.
Sabatier R; Finetti P; Cervera N; Lambaudie E; Esterni B; Mamessier E; Tallet A; Chabannon C; Extra JM; Jacquemier J; Viens P; Birnbaum D; Bertucci F
Breast Cancer Res Treat; 2011 Apr; 126(2):407-20. PubMed ID: 20490655
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy.
Kreike B; Halfwerk H; Kristel P; Glas A; Peterse H; Bartelink H; van de Vijver MJ
Clin Cancer Res; 2006 Oct; 12(19):5705-12. PubMed ID: 17020974
[TBL] [Abstract][Full Text] [Related]
10. A high-risk luminal A dominant breast cancer subtype with increased mobility.
Guo L; Chen G; Zhang W; Zhou L; Xiao T; Di X; Wang Y; Feng L; Zhang K
Breast Cancer Res Treat; 2019 Jun; 175(2):459-472. PubMed ID: 30778902
[TBL] [Abstract][Full Text] [Related]
11. Comparative expressed sequence hybridization reveals differential gene expression in morphological breast cancer subtypes.
Vanden Bempt I; Vanhentenrijk V; Drijkoningen M; De Wolf-Peeters C
J Pathol; 2006 Mar; 208(4):486-94. PubMed ID: 16402338
[TBL] [Abstract][Full Text] [Related]
12. Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay.
Perreard L; Fan C; Quackenbush JF; Mullins M; Gauthier NP; Nelson E; Mone M; Hansen H; Buys SS; Rasmussen K; Orrico AR; Dreher D; Walters R; Parker J; Hu Z; He X; Palazzo JP; Olopade OI; Szabo A; Perou CM; Bernard PS
Breast Cancer Res; 2006; 8(2):R23. PubMed ID: 16626501
[TBL] [Abstract][Full Text] [Related]
13. [Classification of preinvasive breast and carcinoma in situ: doubts, controversies, and proposal for new categorizations].
Dauplat MM; Penault-Llorca F
Bull Cancer; 2004 Dec; 91 Suppl 4():S205-10. PubMed ID: 15899609
[TBL] [Abstract][Full Text] [Related]
14. Refinement of breast cancer classification by molecular characterization of histological special types.
Weigelt B; Horlings HM; Kreike B; Hayes MM; Hauptmann M; Wessels LF; de Jong D; Van de Vijver MJ; Van't Veer LJ; Peterse JL
J Pathol; 2008 Oct; 216(2):141-50. PubMed ID: 18720457
[TBL] [Abstract][Full Text] [Related]
15. DNA copy number alterations and expression of relevant genes in triple-negative breast cancer.
Han W; Jung EM; Cho J; Lee JW; Hwang KT; Yang SJ; Kang JJ; Bae JY; Jeon YK; Park IA; Nicolau M; Jeffrey SS; Noh DY
Genes Chromosomes Cancer; 2008 Jun; 47(6):490-9. PubMed ID: 18314908
[TBL] [Abstract][Full Text] [Related]
16. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
Sørlie T; Wang Y; Xiao C; Johnsen H; Naume B; Samaha RR; Børresen-Dale AL
BMC Genomics; 2006 May; 7():127. PubMed ID: 16729877
[TBL] [Abstract][Full Text] [Related]
17. Molecular evolutionary patterns in breast cancer.
Shackney SE; Silverman JF
Adv Anat Pathol; 2003 Sep; 10(5):278-90. PubMed ID: 12973049
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer pathology: the impact of molecular taxonomy on morphological taxonomy.
Masuda S
Pathol Int; 2012 May; 62(5):295-302. PubMed ID: 22524656
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer.
Kolacinska A; Chalubinska J; Zawlik I; Szymanska B; Borowska-Garganisz E; Nowik M; Fendler W; Kubiak R; Pawlowska Z; Morawiec Z; Szemraj J
Neoplasma; 2012; 59(4):424-32. PubMed ID: 22489698
[TBL] [Abstract][Full Text] [Related]
20. Classification of breast carcinomas according to gene expression profiles.
Moldovan L; Mitroi A; Petrescu CM; Aschie M
J Med Life; 2013 Mar; 6(1):14-7. PubMed ID: 23599813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
